Hydralazine-ISDN in Patients With Chronic Heart Failure - Hydralazine Heart Failure Trial (H-HeFT)
Metformin in Patients with Chronic Heart Failure and Diabetes or Insulin Resistance - Metformin Heart Failure Trial (Met-HeFT)
A randomized, 2 x 2 factorial designed, double-blind, placebo controlled study (DANHEART).
Not yet recruitingCTIS2024-514212-27-00
Aarhus UniversitetshospitalHeart failure
Target: 1500Updated: 2025-11-28